Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page
- Check6 days agoChange DetectedThe history now includes a new revision entry v3.6.5 and removes the previous revision v3.6.4, reflecting an update to the page's version tracking.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe record history shows a new software revision, v3.6.4, replacing the previous v3.6.3. This reflects a back-end or UI update to the page history display and does not alter study data or status.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedNew revision entry v3.6.3 was added to the history. The previous revision v3.6.2 was removed, updating the documented version trail for the study record.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study record history now includes revision v3.6.2, replacing the prior revision v3.6.0. This reflects an administrative update to the page's versioning rather than a change to trial data or conduct.SummaryDifference0.1%

- Check63 days agoChange DetectedA new version v3.6.0 was added with an explicit note that the study is no longer looking for participants. The previous revision v3.5.5 was deleted from the history.SummaryDifference0.5%

- Check70 days agoChange DetectedA new revision tag (v3.5.5) was added and the previous tag (v3.5.4) was removed. This updates the page’s version label in the history view to reflect the latest revision.SummaryDifference0.1%

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.